UnitedHealth Group (UNH)
306.15
-5.17 (-1.66%)
NYSE · Last Trade: Jun 16th, 12:35 PM EDT
Detailed Quote
Previous Close | 311.32 |
---|---|
Open | 313.00 |
Bid | 306.05 |
Ask | 306.25 |
Day's Range | 304.79 - 313.27 |
52 Week Range | 248.88 - 630.73 |
Volume | 7,602,765 |
Market Cap | 278.60B |
PE Ratio (TTM) | 12.82 |
EPS (TTM) | 23.9 |
Dividend & Yield | 8.400 (2.74%) |
1 Month Average Volume | 23,496,762 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
Via Benzinga · June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · June 16, 2025
Rob Sechan recommends buying Alphabet Inc on CNBC's Halftime Report Final Trades, citing its strong performance and low price. Ericsson and Alphabet teamed up for new software platform. NB Private Wealth's CIO picks iShares U.S. Energy ETF. Schlumberger, UnitedHealth also mentioned.
Via Benzinga · June 16, 2025
These two S&P 500 stocks, which fell between 18.2% and 26.6% in May, are worth watching.
Via The Motley Fool · June 15, 2025
The Dow Jones index could have fared better in May if not for these two stocks.
Via The Motley Fool · June 14, 2025
Via The Motley Fool · June 14, 2025
UnitedHealth Group's recent dividend boost and strategic divestiture efforts, combined with executive stock purchases, highlight its strong investment appeal.
Via MarketBeat · June 13, 2025
Via Benzinga · June 13, 2025
Via The Motley Fool · June 12, 2025
Via The Motley Fool · June 12, 2025
Via Benzinga · June 11, 2025
Via Benzinga · June 10, 2025
What a brutal six months it’s been for UnitedHealth. The stock has dropped 46.3% and now trades at $303.30, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · June 10, 2025
UnitedHealth is reviewing four bids for its Latin American unit Banmedica, aiming to finalize a sale amid financial setbacks and leadership changes.
Via Benzinga · June 9, 2025
According to Reuters, UnitedHealth has received four preliminary bids for Banmedica and could set a deadline for binding offers as early as July.
Via Stocktwits · June 9, 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · June 9, 2025
Two of the most covered stocks this year are Palantir and UnitedHealth Group, but the reasons why couldn't be further apart.
Via The Motley Fool · June 8, 2025
Shares of UnitedHealth Group have experienced an epic sell-off over the last month.
Via The Motley Fool · June 8, 2025
On 6 June, UnitedHealth (UNH) increased its dividend by 5.24%, from $2.10 to $2.21¢ per share. Payable June 24; for shareholders of record June 16; ex-div June 16.
Via Talk Markets · June 8, 2025
Here are three stocks that each have oversold RSIs. However, improving signals and catalysts could suggest we're looking at some great entry points.
Via MarketBeat · June 7, 2025